1. Academic Validation
  2. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis

TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis

  • Free Radic Biol Med. 2024 Jul:219:141-152. doi: 10.1016/j.freeradbiomed.2024.04.224.
Liu Yang 1 Zeyu Peng 1 Fanpeng Gong 1 WenXin Yan 1 Yi Shi 1 Hanyi Li 1 Chang Zhou 1 Hong Yao 1 Menglu Yuan 1 Fan Yu 1 Lei Feng 1 Naifu Wan 2 Guizhu Liu 3
Affiliations

Affiliations

  • 1 Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • 2 Department of Vascular & Cardiology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • 3 Wuxi School of Medicine, Jiangnan University, Wuxi, China. Electronic address: liuguizhu@jiangnan.edu.cn.
Abstract

Pulmonary hypertension (PH) is a devastating disease that lacks effective treatment options and is characterized by severe pulmonary vascular remodeling. Pulmonary arterial endothelial cell (PAEC) dysfunction drives the initiation and pathogenesis of pulmonary arterial hypertension. Canonical transient receptor potential (TRPC) channels, a family of CA2+-permeable channels, play an important role in various diseases. However, the effect and mechanism of TRPCs on PH development have not been fully elucidated. Among the TRPC family members, TRPC4 expression was markedly upregulated in PAECs from hypoxia combined with SU5416 (HySu)-induced PH mice and monocrotaline (MCT)-treated PH rats, as well as in hypoxia-exposed PAECs, suggesting that TRPC4 in PAECs may participate in the occurrence and development of PH. In this study, we aimed to investigate whether TRPC4 in PAECs has an aggravating effect on PH and elucidate the molecular mechanisms. We observed that hypoxia treatment promoted PAEC Apoptosis through a caspase-12/endoplasmic reticulum stress (ERS)-dependent pathway. Knockdown of TRPC4 attenuated hypoxia-induced Apoptosis and Caspase-3/caspase-12 activity in PAECs. Accordingly, adeno-associated virus (AAV) serotype 6-mediated pulmonary endothelial TRPC4 silencing (AAV6-Tie-shRNA-TRPC4) or TRPC4 antagonist suppressed PH progression as evidenced by reduced right ventricular systolic pressure (RVSP), pulmonary vascular remodeling, PAEC Apoptosis and Reactive Oxygen Species (ROS) production. Mechanistically, unbiased RNA Sequencing (RNA-seq) suggested that TRPC4 deficiency suppressed the expression of the proapoptotic protein sushi domain containing 2 (Susd2) in hypoxia-exposed mouse PAECs. Moreover, TRPC4 activated hypoxia-induced PAEC Apoptosis by promoting Susd2 expression. Therefore, inhibiting TRPC4 ameliorated PAEC Apoptosis and hypoxic PH in Animals by repressing Susd2 signaling, which may serve as a therapeutic target for the management of PH.

Keywords

Apoptosis; Pulmonary arterial endothelial cells; Pulmonary hypertension; TRPC4 channel.

Figures
Products